Advertisement

N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Pregnancy could be associated with a state of oxidative stress that could initiate and propagate a cascade of changes that may lead to pregnancy wastage. This process of oxidative stress may be suppressed by the antioxidant effect of N-acetyl cysteine (NAC). The current study aimed to evaluate the effect of NAC therapy in patients diagnosed with unexplained recurrent pregnancy loss (RPL). The study was a prospective controlled study performed in the Women's Health Centre, Assiut University, Egypt. A group of 80 patients with history of recurrent unexplained pregnancy loss were treated with NAC 0.6 g + folic acid 500 μg/day and compared with an aged-matched group of 86 patients treated with folic acid 500 μg/day alone. NAC + folic acid compared with folic acid alone caused a significantly increased rate of continuation of a living pregnancy up to and beyond 20 weeks [P < 0.002, relative risk (RR) 2.9, 95% confidence interval (CI) 1.5–5.6]. NAC + folic acid was associated with a significant increase in the take-home baby rate as compared with folic acid alone (P < 0.047, RR 1.98, 95% CI 1.3–4.0). In conclusion, NAC is a well-tolerated drug that could be a potentially effective treatment in patients with unexplained RPL.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Agarwal A
        • Gupta S
        • Sharma R
        Oxidative stress and its implications in female infertility – a clinician's perspective.
        Reproductive BioMedicine Online. 2005; 11: 641-650
        • Aluigi MG
        • De Flora S
        • D'Agostini F
        • et al.
        Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin.
        Anticancer Research. 2000; 20: 3183-3187
        • American College of Obstetricians and Gynecologists
        Management of recurrent pregnancy loss. Practice Bulletin Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995).
        International Journal of Gynaecology and Obstetrics. 2000; 78: 179-190
        • Buhimschi IA
        • Buhimschi CS
        • Weiner CP
        Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation.
        American Journal of Obstetrics and Gynaecology. 2003; 188: 203-208
        • Choi HK
        • Choi BC
        • Lee SH
        • et al.
        Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients.
        Molecular Reproduction and Development. 2003; 66: 24-31
        • Cotgreave IA
        N-acetylcysteine: pharmacological considerations and experimental and clinical applications.
        Advances in Pharmacology. 1997; 38: 205-227
        • Halliwell B
        Antioxidants in human health and disease.
        Annual Review of Nutrition. 1996; 16: 33-50
        • Hempstock J
        • Jauniaux E
        • Greenwold N
        • Burton GJ
        The contribution of placental oxidative stress to early pregnancy failure.
        Human Pathology. 2003; 34: 1265-1275
        • Jauniaux E
        • Burton GJ
        Pathophysiology of histological changes in early pregnancy loss.
        Placenta. 2005; 26: 114-123
        • Jauniaux E
        • Gulbis B
        • Burton GJ
        Physiological implications of the materno-fetal oxygen gradient in human early pregnancy.
        Reproductive Biomedicine Online. 2003; 7: 250-253
        • Jauniaux E
        • Hempstock J
        • Greenwold N
        • Burton GJ
        Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies.
        American Journal of Pathology. 2003; 162: 115-125
        • Jauniaux E
        • Watson AL
        • Hempstock J
        • et al.
        Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure.
        American Journal of Pathology. 2000; 157: 2111-2122
        • Jenkins C
        • Wilson R
        • Roberts J
        • et al.
        Antioxidants: their role in pregnancy and miscarriage.
        Antioxidants and Redox Signaling. 2000; 2: 623-628
        • Kelly GS
        Clinical applications of N-acetylcysteine.
        Alternative Medicine Review. 1998; 3: 114-127
        • Lappas M
        • Permezel M
        • Rice GE
        N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro.
        Journal of Clinical Endocrinology and Metabolism. 2003; 88: 1723-1729
        • Myatt L
        • Cui X
        Oxidative stress in the placenta. histochemistry and cell biology.
        Histochemistry and Cell Biology. 2004; 122: 369-382
        • Ohyama K
        • Yuan B
        • Bessho T
        • Yamakawa T
        Progressive apoptosis in chorion laeve trophoblast cells of human fetal membrane tissues during in-vitro incubation is suppressed by antioxidative reagents.
        European Journal of Biochemistry. 2001; 268: 6182-6189
        • Ornaghi F
        • Ferrini S
        • Prati M
        • Giavini E
        The protective effects of N-acetyl-l-cysteine against methyl mercury embryotoxicity in mice.
        Fundamental and Applied Toxicology. 1993; 20: 437-445
        • Poston L
        • Raijmakers MT
        Trophoblast oxidative stress, antioxidants and pregnancy outcome – a review.
        Placenta. 2004; 25: S72-S78
        • Quadrilatero J
        • Hoffman-Goetz L
        N-Acetyl-l-cysteine prevents exercise-induced intestinal lymphocyte apoptosis by maintaining intracellular glutathione levels and reducing mitochondrial membrane depolarization.
        Biochemical and Biophysical Research Communications. 2004; 319: 894-901
        • Riggs BS
        • Bronstein AC
        • Kulig K
        • Archer PG
        • Rumack BH
        Acute acetaminophen overdose during pregnancy.
        Obstetrics and Gynecology. 1989; 74: 247-253
        • Rizk AY
        • Bedaiwy MA
        • Al-Inany HG
        N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome.
        Fertility and Sterility. 2005; 83: 367-370
        • Roes EM
        • Raijmakers MT
        • Boo TM
        • et al.
        Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia.
        European Journal of Obstetrics, Gynecology and Reproductive Biology. 2006; 127: 61-67
        • Wentzel P
        • Thunberg L
        • Eriksson UJ
        Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture.
        Diabetologia. 1997; 40: 7-14
        • Xu DX
        • Chen YH
        • Wang H
        • et al.
        Effect of N-acetylcysteine on lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice.
        Toxicological Sciences. 2005; 88: 525-533

      Biography

      Professor Amin obtained his medical degree in 1985 from Assiut Medical School, Egypt, and received specialty training at the same University leading to MSc and PhD degrees in Obstetrics and Gynaecology. His current position is Professor of Obstetrics and Gynaecology at the Assiut Medical School. In 1991, he received a Diploma in Endoscopic Surgery from Kiel University, Germany. He obtained the International Journal of Gynecology and Obstetrics prize paper award for best clinical research article from a developing country in 2003, and in 2007 Assiut University awarded him a distinction prize in the field of Medical Science. He has more than 50 international and national publications.